Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late-onset Parkinson's disease in subjects 70 years and older: use of rotigotine
2013-000827-15Phase 2Completed
- Sponsor
- Neurodegenerative Diseases Unit, Cardinal Giovanni Panico Hospital
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rotigotine in Parkinson's disease (PD), sponsored by Neurodegenerative Diseases Unit, Cardinal Giovanni Panico Hospital. Primary endpoint: Primary responder rate at 4 months. Started Mar 2013; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2013-000827-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000827-15.